BioROSA Technologies Inc.
Creating a biologically-based diagnostic standard of care for autism spectrum disorders
- Founded
- 2017
- Employees*
- 2-10
- Funding to Date*
- undisclosed
- Website
- biorosa.com
"There is no simple blood test to detect early and intervene when behavioral treatments are most effective."
Autism behavioral diagnosis and treatment is covered by insurance in all 50 states
Over 30 million children and over 100 million people around the world live with autism spectrum disorders (ASD). BioROSA is challenging the status quo by developing cost-effective, fast, and simple diagnostic tools to allow clinicians to easily determine who is at risk for ASD, simplify the diagnostic process, and enable therapeutic developments. We do this through powerful blood-based biomarkers and machine learning tools.
More Companies